Chronic pain management in patients with substance use disorders

Advanced Studies in Medicine

Volumn 6, Issue 3, 2006, Pages 111-123

  Olsen, Yngvild ^a,b,e   Alford, Daniel P ^c,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Boston Public Health Commissions   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ANTIDEPRESSANT AGENT; BUPRENORPHINE; DISULFIRAM; FENTANYL; ILLICIT DRUG; LOCAL ANESTHETIC AGENT; LONG ACTING DRUG; METHADONE; MORPHINE; MUSCLE RELAXANT AGENT; NALTREXONE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; SHORT ACTING DRUG;

ACUPUNCTURE; ALCOHOLISM; ALTERNATIVE MEDICINE; ANAMNESIS; CHRONIC PAIN; CLINICAL FEATURE; CLINICAL STUDY; CONSENSUS; DISEASE SEVERITY; DRUG ANTAGONISM; DRUG MEGADOSE; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; MENTAL DISEASE; OPIATE ADDICTION; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; REVIEW; SUBSTANCE ABUSE; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

EID: 33645113513     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. Turk DC, Brody MC, Okifuji EA. Physicians' attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain. Pain. 1994;59:201-208.
2. Miller NS, Sheppard LM, Colenda CC, Magen J. Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders. Acad Med. 2001;76:410-418.
3. Portenoy RK, Dole V, Joseph H, et al. Pain management and chemical dependency. Evolving perspectives. JAMA. 1997;278:592-593.
4. Gilson AM, Joranson DE, Maurer MA. Improving state medical board policies: influence of a model. J Law Med Ethics. 2003;31:119-129.
5. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain. 1997;13:6-8.
6. American Society of Addiction Medicine. 34th Annual Meeting and Medical-Scientific Conference. Available at: www.asam.org/Sitemap. htm#CONFERENCES%20AND%20MEDICAL%20EDUCATION. Accessed Jan 5, 2006.
7. American Society of Addiction Medicine. Pain and addiction medicine. Available at: www.asam.org/pain/pain_and_addiction_medicine.htm. Accessed Jan 5, 2006.
8. Savage SR, Joranson DE, Covington EC, Schnoll SH, Heit HA, Gilson AM. Definitions related to the medical use of opioids: evolution towards universal agreement. J Pain Symptom Manage. 2003;26:655-667.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Arlington, Va: American Psychiatric Association; 2000.
10. Savage SR, Covington EC, Heit HA, Hunt J, Joranson DE, Schnoll SH. Definitions related to the use of opioids for the treatment of pain. A consensus statement from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine. Glenview, Ill; 2001.
11. Valigra L. Painful realities: The business of pain management has become almost as complex as treating pain itself. Am Med News. Dec 14, 1998.
12. Harstall C, Ospina M. How prevalent is chronic pain? Pain Clin Updates. 2003;11:1-4.
13. Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289:2370-2378.
14. Brown LS Jr. Enrollment of drug abusers in HIV clinical trials: a public health imperative for communities of color. J Psychoactive Drugs. 1993;25:45-52.
15. Anand A, Carmosino L, Glatt AE. Evaluation of recalcitrant pain in HIV-infected hospitalized patients. J Acquir Immune Defic Syndr. 1994;7:52-56.
16. Breitbart W, Rosenfeld B, Passik S, Kaim M, Funesti-Esch J, Stein K. A comparison of pain report and adequacy of analgesic therapy in ambulatory AIDS patients with and without a history of substance abuse. Pain. 1997;72:235-243.
17. Jamisan RN, Kauffman J, Katz NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage. 2000;19:53-62.
18. Trafton JA, Oliva EM, Horst DA, Minkel JD, Humphreys K. Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend. 2004;73:23-31.
19. Mertens JR, Lu YW, Parthasarathy S, Moore C, Weisner CM. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Arch Intern Med. 2003;163:2511-2517.
20. Adams NJ, Plane MB, Fleming MF, Mundt MP, Saunders LA, Stauffacher EA. Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage. 2001;22:791-796.
21. Verhaak PF, Kerssens JJ, Dekker J, Sorbi MJ, Bensing JM. Prevalence of chronic benign pain disorder among adults: a review of the literature. Pain. 1998;77:231-239.
22. Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic non-cancer pain syndromes in primary care. J Gen Intern Med. 2002;17:173-179.
23. Breitbart W, Rosenthal BD, Passik SD, McDonald MV, Thaler H, Portenoy R. The undertreatment of pain in ambulatory AIDS patients. Elsevier Science B.V. 1996;65:243-249.
24. Karasz A, Zallman L, Berg K, Gourevitch M, Selwyn P, Arnsten JH. The experience of chronic severe pain in patients undergoing methadone maintenance treatment. J Pain Symptom Manage. 2004;28:517-525.
25. Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA. Mutual mistrust in the medical care of drug users: the keys to the "narc" cabinet. J Gen Intern Med. 2002;17:327-333.
26. Breitbart W, Passik S, McDonald MV, et al. Patient-related barriers to pain management in ambulatory AIDS patients. Pain. 1998;76:9-16.
27. Scimeca MM, Savage SR, Portenoy R, Lowinson J. Treatment of pain in methadone-maintained patients. Mt Sinai J Med. 2000;67:412-422.
28. The American Pain Society. Pain: the fifth vital sign. Available at: www.ampainsoc.org/advocacy/fifth.htm. Accessed April 2, 2003.
29. Federation of State Medical Boards. Model policy for the use of controlled substances for the treatment of pain. Available at: www.fsmb.org/Policy%20Documents%20and%20White%20Papers/2004_model_pain_policy. asp. Accessed Sept 11, 2005.
30. Savage SR. Opioid use in the management of chronic pain. Med Clin North Am. 1999;83:761-786.
31. Lander J. Fallacies and phobias about addiction and pain. Br J Addict. 1990;85:803-809.
32. Morgan JP. American opiophobia: customary underutilization of opioid analgesics. Adv Alcohol Subst Abuse. 1985;5:163-173.
33. Breitbart W, Kaim M, Rosenfeld B. Clinicians' perceptions of barriers to pain management in AIDS. J Pain Symptom Manage. 1999;18:203-212.
34. Saitz R, Friedmann PD, Sullivan LM, et al. Professional satisfaction experienced when caring for substance-obusing patients: faculty and resident physician perspectives. J Gen Intern Med. 2002;17:373-376.
35. Duszynski KR, Nieto FJ, Valente CM. Reported practices, attitudes, and confidence levels of primary care physicians regarding patients who abuse alcohol and other drugs. Md Med J. 1995;44:439-446.
36. Kaczor B. US FL: Panhandle Doctor's OxyContin conviction to send message. Denver Rocky Mountain News 2002. Available at: www.mapinc.org/drugnews/v02/ n298/o11.html. Accessed March 16, 2003.
37. Albert T, Adams D. OxyContin crackdown raises physician, patient concerns. Amednews.com; The Newspaper for America's Physicians 2001, June 25.
38. Okie S. California jury finds doctor negligent in managing pain. Washington Post. 2001; June 15: sect A:A02.
39. Hill CS Jr. Government regulatory influences on opioid prescribing and their impact on the treatment of pain of nonmalignant origin. J Pain Symptom Manage. 1996;11:287-298.
40. Gilson AM, Joranson DE. U.S. policies relevant to the prescribing of opioid analgesics for the treatment of pain in patients with addictive disease. Clin J Pain 2002;18(4, suppl):S91-S98.
41. Olsen Y, Daumit GL. Opioid prescribing for chronic nonmalignant pain in primary care: challenges and solutions. Adv Psychosom Med. 2004;25:138-150.
42. Primm BJ, Perez L, Dennis GC, et al. Managing pain: the challenge in underserved populations: appropriate use versus abuse and diversion. J Natl Med Assoc. 2004;96:1152-1161.
43. Collins ED, Streltzer J. Should opioid analgesics be used in the management of chronic pain in opiate addicts? Am J Addict. 2003;12:93-100.
44. Marcus KS, Kerns RD, Rosenfeld B, Breitbart W. HIV/AIDS-related pain as a chronic pain condition: implications of a biopsychosocial model for comprehensive assessment and effective management. Pain Med. 2000;1:260-273.
45. Graham AW, Schultz TK, Mayo-Smith MF, Ries RK, Wilford BB, eds. Principles of Addiction Medicine. 3rd ed. Chevy Chase, Md: American Society of Addiction Medicine, Inc; 2003.
46. Mason BJ, Kacsis JH, Melia D, et al. Psychiatric comorbidity in methadone maintained patients. J Addict Dis. 1998;17:75-89.
47. Watkins KE, Hunter SB, Wenzel SL, et al. Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment. Am J Drug Alcohol Abuse. 2004;30:749-764.
48. Ross HE, Glaser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry. 1988;45:1023-1031.
49. Rounsaville BJ, Weissman MM, Kleber H, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry. 1982;39:161-168.
50. Ericsson M, Poston WS, Linder J, Taylor JE, Haddock CK, Foreyt JP. Depression predicts disability in long-term chronic pain patients. Disabil Rehabil. 2002;24:334-340.
51. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain. 1997;13:116-137.
52. Compton P, Gebhart G. The neurophysiology of pain and interfaces with addiction. In: Graham AW, Schultz TK, Mayo-Smith MF, Ries RK, Wilford BB, eds. Principles of Addiction Medicine. 3rd ed. Chevy Chase, Md: American Society of Addiction Medicine; 2003:1385-1404.
53. Martin JE, Inglis J. Pain tolerance and narcotic addiction. Br J Soc Clin Psychol. 1965;4:224-229.
54. Savage SR, Schofferman J. Pharmacological therapies of pain in drug and alcohol addictions. In: Miller N, Gold M, eds. Pharmacological Therapies for Drug and Alcohol Addictions. New York: Dekker; 1994:373-409.
55. Compton MA. Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status. J Pain Symptom Manage. 1994;9:462-473.
56. Compton P. Pain tolerance in opioid addicts on and off naltrexone pharmacotherapy: a pilot study. J Pain Symptom Manage. 1998;16:21-28.
57. White JM. Pleasure into pain: the consequences of long-term opioid use. Addict Behav. 2004;29:1311-1324.
58. Compton P, Charuvastra VC, Ling W. Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug Alcohol Depend. 2001;63:139-146.
59. Compton P, Charuvastra VC, Kintaudi K, Ling W. Pain responses in methadone-maintained opioid abusers. J Pain Symptom Manage. 2000;20:237-245.
60. Mogil JS, Marek P, Flodman P, et al. One or two genetic loci mediate high opiate analgesia in selectively bred mice. Pain. 1995;60:125-135.
61. Mogil JS, Sternberg WF, Marek P, Sadowski B, Belknap JK, Liebeskind JC. The genetics of pain and pain inhibition. Proc Natl Acad Sci USA. 1996;93:3048-3055.
62. Belknap JK, Mogil JS, Helms ML, et al. Localization to chromosome 10 of a lacus influencing morphine analgesia in crosses derived from C57BL/6 and DBA/2 strains. Life Sci. 1995;57:L117-L124.
63. Bond C, LaForge KS, Tian M, et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci SA. 1998;95:9608-9613.
64. Lehofer M, Liebmann PM, Moser M, et al. Decreased nociceptive sensitivity: a biological risk marker for opiate dependence? Addiction. 1997;92:163-166.
65. Turk DC, Melzack R, eds. Handbook of Pain Assessment. 2nd ed. New York: The Guilford Press; 2001.
66. Breitbart W. Pain management and psychosocial issues in HIV and AIDS. Am J Hosp Palliat Care. 1996;13:20-29.
67. Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory far chronic nanmalignant pain. J Pain. 2004;5:133-137.
68. Saunders JB, Aasland OG, Babor TF, de IF Jr, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT]: WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction. 1993;88:791-804.
69. Westermeyer J, Yargic I, Thuras P. Michigan assessment-screening test for alcohol and drugs (MAST/AD): evaluation in a clinical sample. Am J Addict. 2004;13:151-162.
70. Sacks JA, Drab RE, Williams VF, Banks SM, Herrell JM. Utility of the Time-Line Follow-Back to assess substance use among homeless adults. J Nerv Ment Dis. 2003;191:145-153.
71. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychosociol services in substance abuse treatment. JAAM. 1993;269:1953-1959.
72. McCaul ME, Petry NM. The role of psychosocial treatments in pharmacotherapy for alcoholism. Am J Addict. 2003;12(suppl 1):S41-S52.
73. Chapman SL, Jamison RN, Sanders SH, Lyman DR, Lynch NT. Perceived treatment helpfulness and cost in chronic pain rehabilitation. Clin J Pain. 2000;16:169-177.
74. Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Kate NP. Opioid therapy for chronic noncancer back pain. A randomized prospective study. Spine. 1998;23:2591-2600.
75. Practice guidelines for chronic pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Chronic Pain Section. Anesthesiology. 1997;86:995-1004.
76. Isaacson JH, Hopper JA, Alford DP, Parran T. Prescription drug use and abuse. Risk factors, red flags, and prevention strategies. Pastgrad Med. 2005;118:19-26.
77. Gallagher RM. Primary care and pain medicine. A community solution to the public health problem of chronic pain. Med Clin North Am. 1999;83:555-583.
78. 106th Congress. Drug Addiction Treatment Act of 2000. Title XXXV of Public Low 106-310, Section 3501-3503.
79. Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003; 349:949-958.
80. Fiellin DA, Pantalon MV, Pakes JP, O'Connor PG, Chawarski M, Schottenfeld RS. Treatment of heroin dependence with buprenorphine in primary care. Am J Drug Alcohol Abuse. 2002;28:231-241.
81. Malinoff HI, Barkin RL, Wilson G. Sublingual buprenorphine is effective in the treatment of chronic pain syndrome. Am J Ther. 2005;12:379-384.
82. Fiellin DA, O'Connor PG. New federal initiatives to enhance the medical treatment of opioid dependence. Ann Intern Med. 2002;137:688-692.
83. Fuller RK, Roth HP. Disulfiram for the treatment of alcoholism. An evaluation in 128 men. Ann Intern Med. 1979;90:901-904.
84. Anton RF, Swift RM. Current pharmacotherapies of alcoholism: a US perspective. Am J Addict. 2003;12(suppl 1]:553-568.
85. Boothby LA, Doering PL. Acamprosate for the treatment of alcohol dependence. Clin Ther. 2005;27:695-714.
86. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction: A Treatment Improvement Protocol (TIP) Series 40. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004a. DHHS publication (SMA) 05-4003.
87. Margolin A, Kleber HD, Avants SK, et al. Acupuncture for the treatment of cacaine addiction: a randomized controlled trial. JAMA. 2002;287:55-63.
88. Assefi NP, Sherman KJ, Jacobsen C, Goldberg J, Smith WR, Buchwald D. A randomized clinical trial of acupuncture compared with sham acupuncture in fibromyalgia. Ann intern Med. 2005;143:10-19.
89. van Tulder MW, Gherkin DC, Berman B, Lao L, Koes BW. The effectiveness of acupuncture in the management of acute and chronic low back pain. A systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine. 1999;24:1113-1123.
90. NIH Consensus Conference. Acupuncture. JAMA. 1998; 280:1518-1524.
91. Ernst E, White AR. Acupuncture for back pain: a meta-analysis of randomized controlled trials. Arch Intern Med. 1998;158:2235-2241.
92. Hayden JA, van Tulder MW, Malmivaara AV, Koes BW. Meta-analysis: exercise therapy for nonspecific low back pain. Ann Intern Med. 2005;142:765-775.
93. Khadilkar A, Milne S, Brosseau L, et al. Transcutoneous electrical nerve stimulation (TENS) for chronic low-back pain. Cocnrane Database Syst Rev. 2005;CD003008.
94. Bronfort G, Haas M, Evans RL, Bouter LM. Efficacy of spinal manipulation and mobilization for low back pain and neck pain: a systematic review and best evidence synthesis. Spine J. 2004;4:335-356.
95. Sherman KJ, Cherkin DC, Erro J, Miglioretti DL, Deyo RA. Comparing yoga, exercise, and a self-care book for chronic low back pain: a randomized, controlled trial. Ann Intern Med. 2005;143:849-856.
96. Watoch H, Guthlin C, Konig M. Efficacy of message therapy in chronic pain: a pragmatic randomized trial. J Altern Complement Med. 2003;9:837-846.
97. Hall J, Skevington SM, Maddison PJ, Chapman K. A randomized and controlled trial of hydrotherapy in rheumatoid arthritis. Arthritis Care Res. 1996;9:206-215.
98. Strauss-Blosche G, Ekmekcioglu C, Vacariu G, Melchart H, Fialka-Moser V, Marktl W. Contribution of individual spa therapies in the treatment of chronic pain. Clin J Pain. 2002;18:302-309.
99. Cherkin DC, Sherman KJ, Deyo RA, Shekelle PG. A review of the evidence for the effectiveness, safety, and cost of acupuncture, massage therapy, and spinal manipulation for back pain. Ann Intern Med. 2003;138:898-906.
100. Furlan AD, Brosseau L, Imamura M, Irvin E. Massage for low-back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine. 2002;27:1896-1910.
101. Miller E. The World Health Organization analgesic ladder. J Midwifery Womens Health. 2004;49:542-545.
102. Benjamin LJ, Dampier CC, Jacox AK, et al. Guideline for the Management of Acute and Chronic Pain in Sickle-Cell Disease. IAPS Clinical Practice Guideline Series No.11. Glenview, III: American Pain Society; 1999.
103. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain. 2005;118:289-305.
104. Weaver MF, Schnoll SH. Opioid treatment of chronic pain in patients with addiction. J Pain Palliat Care Pharmacother. 2002;16:5-26.
105. Borg L, Kreek MJ. The pharmacology of opioids. In: Graham AW, Schultz TK, Mayo-Smith MF, Ries RK, Wilford BB, eds. Principles of Addiction Medicine. 3rd ed. Chevy Chase, Md: American Society of Addiction Medicine, Inc; 2003:141-153.
106. MacPherson RD. The pharmacological basis of contemporary pain management. Pharmacol Ther. 2000;88:163-185.
107. Evers GC. Pseudo-opioid-resistant pain. Support Care Cancer. 1997;5:457-460.
108. Alford DP, Compton P, Somet JH. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006;144:127-134.
109. Doverty M, Somogyi AA, White JM, et al. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain. 2001;93:155-163.
110. Fishman SM, Wilsey B, Mahajan G, Molina P. Methadone reincarnated: novel clinical applications with related concerns. Pain Med. 2002;3:339-348.
111. Johnson RE, Fudala PJ, Payne R. Buprenorphine: considerations for pain management. J Pain Symptom Manage. 2005;29:297-326.
112. Dunbar SA, Katz NP. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases. J Pain Symptom Manage. 1996;11:163-171.
113. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic poin. Pain Med. 2005;6:107-112.
114. Passik SD, Weinreb HJ. Managing chronic nonmalignant pain: overcoming obstacles to the use of opioids. Adv Ther. 2000;17:70-83.
115. Fishman SM, Kreis PG. The opioid contract. Clin J Pain. 2002;18(suppl4):S70-S75.
116. Fishman SM, Mahajan G, Jung SW, Wilsey BL. The trilateral opioid contract. Bridging the pain clinic and the primary care physician through the opioid contract. J Pain Symptom Manage. 2002;24:335-344.
117. Heit HA, Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manage. 2004;27:260-267.
118. Substance Abuse and Mental Health Services Administration. Approval and Monitoring of Narcotic Treatment Programs: A Guide an the Roles of Federal and State Agencies. Technical Assistance Publication Series 12. Washington, DC: US Government Printing Office; 1994. DHHS publication (SAM) 94-2082.
119. Gottesman L. Sustiva may cause false positive on marijuana test. WORLD. 1999;96:7.
120. Poklis A, Hall KV, Still J, Binder SR. Ranitidine interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoossay. J Anal Toxical. 1991;15:101-103.
121. Passik SD, Kirsh KL. Managing pain in patients with aberrant drug-taking behaviors. J Support Oncol 2005;3:83-86.
122. Weissman DE, Haddox JD. Opioid pseudoaddiction-an iatrogenic syndrome. Pain. 1989;36:363-366.
123. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain. 1986; 25:171-186.
124. Michna E, Ross EL, Hynes WL, et ai. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage. 2004; 28:250-258.
125. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med. 2005;6:432-442.
126. Chabal C, Erjavec MK, Jacobson L, Mariano A, Chaney E. Prescription opiate obuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain. 1997;13:150-155.
127. Passik SD, Kirsh KL, McDonald MV, et al. A pilot survey of aberrant drug-taking attitudes and behaviors in samples of cancer and AIDS patients. J Pain Symptom Manage. 2000;19:274-286.
128. Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage. 1998;16:355-363.